✦ LIBER ✦

P1072 CONCORDANCE BETWEEN INDICATIONS OF THERAPY AND THE RISK OF HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT IN CHRONIC HEPATITIS B (CHB)

✍ Scribed by Navascués, C.A.; González-Diéguez, M.L.; Alvarez-Argüelles, M.E.; Cadahía, V.; Varela, M.; Martínez-Reglero, C.; Pérez, R.; Martínez-Camblor, P.; Rodríguez, M.

Book ID: 122329706
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 63 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61232-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Su1286 Differences Between Community and

Su1286 Differences Between Community and Academic Cohorts of Patients With Chronic Hepatitis B (CHB) in the Development of Hepatocellular Carcinoma (HCC)

✍ Sonu, Irene; Nguyen, Long H.; Nguyen, Vincent G.; Chen, Christy; Trinh, Huy N.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Patterns of hepatitis B viral load level

Patterns of hepatitis B viral load level (HBV DNA), hepatitis B e antigen (HBeAg) status and risk factors of cirrhosis and hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients in Thailand

✍ S. Leuangarun; T. Sriprayoon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Does interferon therapy for chronic hepa

Does interferon therapy for chronic hepatitis B reduce the risks of developing cirrhosis and hepatocellular carcinoma?

✍ Anna S. F. Lok 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Objective: To estimate the cost-effectiveness of interferon-a2B for the treatment of patients with chronic hepatitis B infection who are positive for hepatitis B e antigen (HBeAg). Design: Meta-analysis of nine randomized controlled trials and cost-effectiveness analysis, projecting the clinical an

T1972 Clinical Presentation of Chronic H

T1972 Clinical Presentation of Chronic Hepatitis B (CHB) and C (CHC) and the Risks for Cirrhosis and/or Hepatic Decompensation (HD) and Hepatocellular Carcinoma (HCC) in Asian Americans

✍ Abbasi, Ali; Pan, Calvin; Xia, Victor W.; Hu, Ke-Qin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 61 KB

886 HTERT PROMOTER GENE POLYMORPHISM AND

886 HTERT PROMOTER GENE POLYMORPHISM AND THE RISK OF HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH CHRONIC HEPATITIS B

✍ J.Y. Park; H.Y. Chang; S.H. Ahn; J.M. Lee; D.Y. Kim; K.S. Lee; C.Y. Chon; Y.M. M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Annual Incidence for Hepatocellular Carc

Annual Incidence for Hepatocellular Carcinoma (HCC) in Non-Cirrhotic Patients With Chronic Hepatitis B (CHB) and Cirrhotic Patients of All Etiologies

✍ Do, Ailinh L. ;Wong, Carrie R. ;Nguyen, Vincent G. ;Garcia, Ruel T. ;Trinh, Huy 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 62 KB